10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 268 filers reported holding 10X GENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $164,400,637 | -28.5% | 3,985,470 | -3.3% | 0.56% | -21.6% |
| Q2 2023 | $230,075,821 | +10.3% | 4,120,269 | +10.2% | 0.71% | +3.9% |
| Q1 2023 | $208,530,077 | +178352.0% | 3,737,768 | +16.6% | 0.69% | +55.8% |
| Q4 2022 | $116,855 | -99.9% | 3,206,783 | -5.4% | 0.44% | +21.8% |
| Q3 2022 | $96,581,000 | -39.5% | 3,391,177 | -3.8% | 0.36% | -34.4% |
| Q2 2022 | $159,591,000 | -34.5% | 3,526,878 | +10.2% | 0.55% | -1.4% |
| Q1 2022 | $243,530,000 | -1.7% | 3,201,394 | +92.4% | 0.56% | +21.7% |
| Q4 2021 | $247,865,000 | – | 1,663,967 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 750,000 | $111,720,000 | 99.68% |
| Foresite Capital Management II, LLC | 1,753,528 | $261,206,000 | 99.34% |
| Venrock Management VI, LLC | 962,309 | $143,346,000 | 96.17% |
| 12 West Capital Management LP | 2,004,000 | $298,516,000 | 13.24% |
| FINANCIAL CONSULATE, INC | 154,942 | $23,080,000 | 8.00% |
| Meritech Capital Associates V L.L.C. | 1,610,824 | $239,948,000 | 7.68% |
| Andar Capital Management HK Ltd | 55,000 | $8,193,000 | 7.52% |
| JS Capital Management LLC | 540,589 | $80,526,000 | 3.66% |
| HARVARD MANAGEMENT CO INC | 186,143 | $27,728,000 | 2.60% |
| Connective Portfolio Management, LLC | 7,000 | $1,056,000 | 1.86% |